103
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Preoperative Fibrinogen–Albumin Ratio, Potential Prognostic Factors for Bladder Cancer Patients Undergoing Radical Cystectomy: A Two-Center Study

ORCID Icon, , ORCID Icon, , , & ORCID Icon show all
Pages 3181-3192 | Published online: 12 Apr 2021

References

  • Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.2149230207593
  • Czerniak B, Dinney C, McConkey D. Origins of bladder cancer. Annu Rev Pathol. 2016;11(1):149–174. doi:10.1146/annurev-pathol-012513-10470326907529
  • Babjuk M, Bohle A, Burger M, et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016. Eur Urol. 2017;71(3):447–461. doi:10.1016/j.eururo.2016.05.04127324428
  • Mao W, Huang X, Wang L, et al. Circular RNA hsa_circ_0068871 regulates FGFR3 expression and activates STAT3 by targeting miR-181a-5p to promote bladder cancer progression. J Exp Clin Cancer Res. 2019;38(1):169. doi:10.1186/s13046-019-1136-930999937
  • Jain A, Zhang Q, Toh HC. Awakening immunity against cancer: a 2017 primer for clinicians. Chin J Cancer. 2017;36(1):67. doi:10.1186/s40880-017-0233-428823251
  • Weisel JW. Fibrinogen and fibrin. Adv Protein Chem. 2005;70:247–299.15837518
  • Seo MH, Choa M, You JS, et al. Hypoalbuminemia, low base excess values, and tachypnea predict 28-day mortality in severe sepsis and septic shock patients in the emergency department. Yonsei Med J. 2016;57(6):1361–1369. doi:10.3349/ymj.2016.57.6.136127593863
  • Tan Z, Zhang M, Han Q, et al. A novel blood tool of cancer prognosis in esophageal squamous cell carcinoma: the fibrinogen/albumin ratio. J Cancer. 2017;8(6):1025–1029. doi:10.7150/jca.1649128529615
  • Xu Q, Yan Y, Gu S, et al. A novel inflammation-based prognostic score: the fibrinogen/albumin ratio predicts prognoses of patients after curative resection for hepatocellular carcinoma. J Immunol Res. 2018;2018:4925498. doi:10.1155/2018/492549830027102
  • Liu J, Gan Y, Song H, Zhu K, Zhang Q. The predictive value of the preoperative fibrinogen-albumin ratio on the postoperative prognosis of renal cell carcinoma. Transl Androl Urol. 2020;9(3):1053–1061. doi:10.21037/tau-19-87332676389
  • Park JH, Moon KC. Tumor, Nodes, Metastases (TNM) Classification System for Bladder Cancer. 2018:181–184.
  • Enquselassie F. 50th anniversary of declaration of Helsinki. Ethiop Med J. 2014;52(1):2p preceding 1.
  • Proctor MJ, Horgan PG, Talwar D, Fletcher CD, Morrison DS, McMillan DC. Optimization of the systemic inflammation-based Glasgow prognostic score: a Glasgow Inflammation Outcome Study. Cancer. 2013;119(12):2325–2332. doi:10.1002/cncr.2801823575969
  • Ferro M, Katalin MO, Buonerba C, et al. Type 2 diabetes mellitus predicts worse outcomes in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guerin after transurethral resection of the bladder tumor. Urol Oncol. 2020;38(5):459–464. doi:10.1016/j.urolonc.2020.02.01632173242
  • Bratek-Skicki A, Zeliszewska P, Ruso JM. Fibrinogen: a journey into biotechnology. Soft Matter. 2016;12(42):8639–8653. doi:10.1039/C6SM01895E27722513
  • Pieters M, Wolberg AS. Fibrinogen and fibrin: an illustrated review. Res Pract Thromb Haemost. 2019;3(2):161–172. doi:10.1002/rth2.1219131011700
  • Lee SY, Song CW, Levitt SH. Change in fibrinogen turnover in tumors by hyperthermia. Eur J Cancer Clin Oncol. 1985;21(12):1507–1513. doi:10.1016/0277-5379(85)90246-93830729
  • Kwaan HC, Lindholm PF. Fibrin and fibrinolysis in cancer. Semin Thromb Hemost. 2019;45(4):413–422. doi:10.1055/s-0039-168849531041799
  • Li S, Lan X, Gao H, et al. Systemic Inflammation Response Index (SIRI), cancer stem cells and survival of localised gastric adenocarcinoma after curative resection. J Cancer Res Clin Oncol. 2017;143(12):2455–2468. doi:10.1007/s00432-017-2506-328828692
  • Mosesson MW. Fibrinogen and fibrin structure and functions. J Thromb Haemost. 2005;3(8):1894–1904. doi:10.1111/j.1538-7836.2005.01365.x16102057
  • Sahni A, Khorana AA, Baggs RB, Peng H, Francis CW. FGF-2 binding to fibrin(ogen) is required for augmented angiogenesis. Blood. 2006;107(1):126–131. doi:10.1182/blood-2005-06-246016160009
  • Ridker PM, Howard CP, Walter V, et al. Effects of interleukin-1beta inhibition with canakinumab on hemoglobin A1c, lipids, C-reactive protein, interleukin-6, and fibrinogen: a phase IIb randomized, placebo-controlled trial. Circulation. 2012;126(23):2739–2748. doi:10.1161/CIRCULATIONAHA.112.12255623129601
  • Mantzorou M, Koutelidakis A, Theocharis S, Giaginis C. Clinical value of nutritional status in cancer: what is its impact and how it affects disease progression and prognosis? Nutr Cancer. 2017;69(8):1151–1176. doi:10.1080/01635581.2017.136794729083236
  • Virizuela JA, Camblor-Alvarez M, Luengo-Perez LM, et al. Nutritional support and parenteral nutrition in cancer patients: an expert consensus report. Clin Transl Oncol. 2018;20(5):619–629. doi:10.1007/s12094-017-1757-429043569
  • Jones CH, Akbani H, Croft DC, Worth DP. The relationship between serum albumin and hydration status in hemodialysis patients. J Ren Nutr. 2002;12(4):209–212. doi:10.1053/jren.2002.3529512382212
  • Watt DG, McSorley ST, Park JH, Horgan PG, McMillan DC. A postoperative systemic inflammation score predicts short- and long-term outcomes in patients undergoing surgery for colorectal cancer. Ann Surg Oncol. 2017;24(4):1100–1109. doi:10.1245/s10434-016-5659-427822634
  • Vartolomei MD, Ferro M, Cantiello F, et al. Validation of neutrophil-to-lymphocyte ratio in a multi-institutional cohort of patients with T1G3 non-muscle-invasive bladder cancer. Clin Genitourin Cancer. 2018;16(6):445–452. doi:10.1016/j.clgc.2018.07.00330077463
  • Ferro M, Di Lorenzo G, Vartolomei MD, et al. Absolute basophil count is associated with time to recurrence in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guerin after transurethral resection of the bladder tumor. World J Urol. 2020;38(1):143–150. doi:10.1007/s00345-019-02754-230993426